Therapeutic Antibody sdAb Discovery & ExpressCMC™ with Cell Line Development Webinar | ProBio CDMO 09-23-2025 / Derek Chen Sr. Director, Antibody Drug Discovery Dept., ProBio...... sdAbs are unique type of antibodies derived from camelids and widely used as therapeutics, especially as building blocks for multi-specific antibodies. Learn More
Therapeutic Antibody Biologics Webinar: From Lab Bench to GMP for BsAb & ADC | ProBio CDMO 07-31-2025 / Join us for an insightful seminar focused on the discovery and development of complex biologics, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs) Learn More
Therapeutic Antibody Bispecific Antibody Webinar | Advancing Challenging Biologics BsAb, ADC & RDC | ProBio CDMO 06-05-2025 / The BioForum ‘Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations’, delivered by BioMelbourne Network in collaboration with ProBio, will discuss how the development of complex biologic therapies – including bi-specific and tri-specific ... Learn More
Therapeutic Antibody Biologics Webinar | Biologics CMC Regulatory, Process & Tech Transfer | ProBio CDMO 03-08-2025 / Tina Yu, Sr. Director of Regulatory Affairs Dept., ProBio As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for success. Gain key insights to drive innovation and overcome challenges. Learn More
Therapeutic Antibody Antibody Discovery Webinar | Functional Antibody Lead Discovery & Engineering | ProBio CDMO 03-04-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. ProBio Functional screening is the most crucial step for the early-stage therapeutic antibody discovery. Currently, most of antibody lead discovery strategy starts with screening for binders, followed by functional characterization with purified antibody. Learn More
Therapeutic Antibody Pre-clinical DMPK Study and Generation of Toolbox to Facilitate PK/ADA Analysis | ProBio CDMO 02-25-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. Animal based DMPK analysis is a crucial component in pre-clinical study of drug candidate. Learn More
Therapeutic Antibody Antibody Engineering and Developablity Service | ProBio CDMO 06-04-2024 / Alex Chen, Head of ADD PM Dept., ProBio The functionality and developability properties of therapeutic antibodies are two major concerns in preclinical development. Addressing the optimization strategy in the discovery stage enables acquiring better antibody candidates before entering CMC. Learn More
Therapeutic Antibody Cost Reduction Strategies in Clinical Stage Process Optimization for Biologics | ProBio CDMO 05-14-2024 / Rubin Jiang, Director of Antibody Process Development & MSAT, ProBio Costly medicines are a burden for both individual patients and national budgets. The Prescription Drug Law within the Inflation Reduction Act (IRA) exemplifies efforts to make medicines more affordable. The production of biologics requires intricate manuf Learn More